Related Experiment Videos

Antimicrobial safety and tolerability: differences and dilemmas

L A Mandell1, P Ball, G Tillotson

  • 1McMaster Medical Unit, Henderson General Hospital, 711 Concession Street, Hamilton, Ontario L8V 1C3, Canada. lmandell@fhs.csu.mcmaster.ca

Insights

Antimicrobial toxicity, including severe adverse drug reactions, is a growing concern. This review examines antimicrobial toxicity mechanisms and fluoroquinolone adverse events, linking them to drug structures.

Area of Science:

  • Pharmacology
  • Toxicology
  • Infectious Diseases

Background:

  • Adverse drug reactions (ADRs) from antimicrobials are a significant clinical concern.
  • Antimicrobial toxicity ranges from mild effects to life-threatening events like seizures and cardiac arrhythmias.

Purpose of the Study:

  • To review general antimicrobial toxicity.
  • To specifically examine fluoroquinolone toxicity and adverse events.
  • To explore structure-adverse event relationships for explaining toxicity.

Main Methods:

  • Review of existing literature on antimicrobial and fluoroquinolone toxicity.
  • Categorization of toxicity mechanisms (direct effects, hypersensitivity, flora changes, drug interactions, lysis).
  • Analysis of organ system involvement and individual fluoroquinolone drugs.

Main Results:

  • Five primary mechanisms explain antimicrobial toxicity.
  • Fluoroquinolone ADRs are explained using these mechanisms.
  • Specific fluoroquinolones like temafloxacin and trovafloxacin exhibited significant adverse events.

Conclusions:

  • Understanding antimicrobial toxicity mechanisms is crucial for patient safety.
  • Fluoroquinolone-associated adverse events require careful consideration.
  • Structure-activity relationships can help predict and explain drug toxicity.

Related Concept Videos